[VIABILITY OF MYOCAROIUM AS RISK FACTOR FOR MORTALITY IN EARLY AND LATE PERIOD AFTER BYPASS SURGERY OF CORONARY

Klinichna Khirurhiia
|November 3, 2015
PubMed

Insights

Patients with coronary heart disease and low left ventricular ejection fraction (LVEF) after bypass surgery face higher mortality and complication risks. Identifying preoperative predictors is crucial for managing these high-risk cardiac patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes

Background:

  • Coronary heart disease (CHD) patients with reduced left ventricular ejection fraction (LVEF) exhibit increased mortality and complications post-coronary artery bypass grafting (CABG).
  • Preserved LVEF in CABG patients is associated with better outcomes compared to those with impaired systolic function.

Purpose of the Study:

  • To identify significant preoperative predictors of early mortality in patients undergoing CABG.
  • To determine the incidence of early postoperative complications in patients with reduced LVEF after CABG.
  • To compare outcomes between patients with preserved and reduced LVEF following CABG.

Main Methods:

  • Retrospective analysis of patient data from coronary artery bypass surgery.
  • Evaluation of preoperative clinical and echocardiographic parameters.
  • Assessment of early postoperative mortality and complication rates.

Main Results:

  • Patients with low LVEF demonstrated significantly higher rates of mortality and complications compared to those with preserved LVEF.
  • Specific preoperative factors were identified as significant predictors of early mortality.
  • The incidence of postoperative complications was notably elevated in the low LVEF group.

Conclusions:

  • Reduced LVEF is a critical factor associated with adverse outcomes after CABG.
  • Preoperative risk stratification is essential for optimizing management strategies in high-risk cardiac surgery patients.
  • Further research should focus on interventions to mitigate risks in patients with impaired LV systolic function undergoing CABG.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
637
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
757
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
426
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
708
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
960